Martínez-López, J.; de la Cruz, J.; Gil-Manso, R.; Yuste, V.J.; Aspa-Cilleruelo, J.M.; Escobar, C.E.; López-Jiménez, J.; Duarte, R.; Yerovi, C.J.; Hernández-Rivas, J.-Á.;
et al. COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant. Cancers 2024, 16, 379.
https://doi.org/10.3390/cancers16020379
AMA Style
Martínez-López J, de la Cruz J, Gil-Manso R, Yuste VJ, Aspa-Cilleruelo JM, Escobar CE, López-Jiménez J, Duarte R, Yerovi CJ, Hernández-Rivas J-Á,
et al. COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant. Cancers. 2024; 16(2):379.
https://doi.org/10.3390/cancers16020379
Chicago/Turabian Style
Martínez-López, Joaquín, Javier de la Cruz, Rodrigo Gil-Manso, Víctor Jiménez Yuste, José María Aspa-Cilleruelo, Cristian Escolano Escobar, Javier López-Jiménez, Rafael Duarte, Cristina Jacome Yerovi, José-Ángel Hernández-Rivas,
and et al. 2024. "COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant" Cancers 16, no. 2: 379.
https://doi.org/10.3390/cancers16020379
APA Style
Martínez-López, J., de la Cruz, J., Gil-Manso, R., Yuste, V. J., Aspa-Cilleruelo, J. M., Escobar, C. E., López-Jiménez, J., Duarte, R., Yerovi, C. J., Hernández-Rivas, J.-Á., Herráez, R., Quiroz-Cervantes, K., Bustelos-Rodriguez, R., Benavente, C., Martínez Barranco, P., Bastos Oteiro, M., Alegre, A., Pérez-Oteyza, J., Ruiz, E.,
... García-Suárez, J., on behalf of the Asociación Madrileña de Hematología y Hemoterapia (AMHH).
(2024). COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant. Cancers, 16(2), 379.
https://doi.org/10.3390/cancers16020379
